Real-World study tests oral diabetes drug in thai patients
NCT ID NCT06507475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at how well oral semaglutide (Rybelsus) works for Thai adults with type 2 diabetes in everyday medical practice. Researchers reviewed medical records of 209 patients over 6 months to measure changes in blood sugar (HbA1c) and body weight. The goal was to see if the drug is effective outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral semaglutide (Rybelsus)
What this could lead to
If successful, this could confirm that oral semaglutide works well in real-world Thai patients, supporting its use for blood sugar and weight control in type 2 diabetes.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. It is also limited to a specific population and short duration.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maharaj Nakorn Chiang Mai Hospital_Nephrology
Chiang Mai, 50200, Thailand